Zobrazeno 1 - 10
of 92
pro vyhledávání: '"Shigeru TOMOYASU"'
Autor:
Ayako Mochizuki, Masamichi Takami, Yoichi Miyamoto, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Yuho Kadono, Sakae Tanaka, Tomio Inoue, Ryutaro Kamijo
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e48795 (2012)
Cells with monocyte/macrophage lineage expressing receptor activator of NF-κB (RANK) differentiate into osteoclasts following stimulation with the RANK ligand (RANKL). Cell adhesion signaling is also required for osteoclast differentiation from prec
Externí odkaz:
https://doaj.org/article/a471e86a225b406c8d8180af94df7102
Autor:
Toshiko Yamochi-Onizuka, Takashi Maeda, Kunihiko Fukuchi, Bungo Saito, Hidetoshi Nakashima, Eisuke Shiozawa, Tsuyoshi Nakamaki, Hidekazu Ota, Hirotsugu Ariizumi, Mayumi Homma, Shigeru Tomoyasu, Kouji Yanagisawa
Publikováno v:
European Journal of Haematology. 89:350-355
In diffuse large B-cell lymphoma (DLBCL), a CD20-negative relapse is clinically significant because it is associated with chemo-refractory phenotypes and loss of a therapeutic target. The alteration of the CD20 gene is reported as infrequent in CD20-
Autor:
Shigeru Tomoyasu, Hidekazu Ota, Takashi Maeda, Toshiko Yamochi-Onizuka, Hidetoshi Nakashima, Isao Matsuda, Bungo Saito, Kunihiko Fukuchi, Kouji Yanagisawa, Mayumi Homma, Tsuyoshi Nakamaki, Hirotsugu Ariizumi, Norimichi Hattori
Publikováno v:
Acta Haematologica. 125:242-246
Autor:
Norimichi Hattori, Takashi Maeda, Hirotsugu Ariizumi, Hidetoshi Nakashima, Shigeru Tomoyasu, Tsuyoshi Nakamaki, Bungo Saito
Publikováno v:
The Showa University Journal of Medical Sciences. 23:75-87
It is difcult to predict the clinical outcome of gemtuzumab ozo- gamicin (GO) therapy based solely on the previously identified predictive factors. We retrospectively analyzed the relationship between clinical factors and outcomes in 12 patients with
Autor:
Shigeru Tomoyasu, Toshiko Yamochi-Onizuka, Tsuyoshi Nakamaki, Norimichi Hattori, Hirotsugu Ariizumi, Mayumi Homma, Hidekazu Ota
Publikováno v:
European Journal of Haematology. 84:448-452
We analyzed a case with the blastoid variant of mantle cell lymphoma (MCL-BV), a rare subtype of B-cell lymphoma, presenting with marked hypercalcemia at diagnosis. Enzyme-linked immunosorbent assay (ELISA) showed elevated serum levels of interleukin
Autor:
Tsuyoshi Nakamaki, Masafumi Takimoto, Norimichi Hattori, Kouji Yanagisawa, Bungo Saito, Hidetoshi Nakashima, Isao Matsuda, Shigeru Tomoyasu, Toshiko Yamochi-Onizuka, Miki Kushima, Hidekazu Ota, Mayumi Homma, Hirotsugu Ariizumi, Eisuke Shiozawa, Takashi Maeda
Publikováno v:
The Showa University Journal of Medical Sciences. 22:51-61
Autor:
Norimichi Hattori, Daisuke Adachi, Bungo Saito, Shigeru Tomoyasu, Hidetoshi Nakashima, Tsuyoshi Nakamaki
Publikováno v:
Leukemia Research. 33:574-577
Autor:
Junko Shimozuma-Suzuki, Daisuke Adachi, Norimichi Hattori, Kouji Yanagisawa, Shigeru Tomoyasu, Hidetoshi Nakashima, Isao Matsuda, Takashi Maeda, Bungo Saito, Mayumi Honma, Keiichiro Kawakami, Takako Takeda-Usui, Tsuyoshi Nakamaki, Jun-ichi Hisatake
Publikováno v:
The Showa University Journal of Medical Sciences. 21:215-225
Autor:
Kouji Yanagisawa, Daisuke Adachi, Shigeru Tomoyasu, Takashi Maeda, Norimichi Hattori, Kunihide Gomi, Hidetoshi Nakashima, Isao Matsuda, Kunihiko Fukuchi, Bungo Saito, Tsuyoshi Nakamaki
Publikováno v:
International Journal of Hematology. 88:181-188
Patients with Ph chromosome negative myeloproliferative disease (Ph-MPD) have an increased risk of vascular complications. It remains controversial whether patients with the JAK2 V617F mutation (V617F) exhibit increased risk, while recent growing evi
Autor:
Norimichi Hattori, Tsuyoshi Nakamaki, Shigeru Tomoyasu, Hidetoshi Nakashima, Toshiko Yamochi-Onizuka, Isao Matsuda, Eisuke Shiozawa, Takashi Maeda, Hidekazu Ota, Bungo Saito, Takako Usui, Daisuke Adachi, Masafumi Takimoto, Homma Mayumi, Kouji Yanagisawa
Publikováno v:
Pathology International. 58:126-132
To study hematopoietic reconstitution in umbilical cord blood transplantation (CBT), bone marrow (BM) histology was investigated in 35 biopsies after bone marrow transplantation (BMT) and in 40 biopsies after CBT. BM biopsies were obtained at differe